Amarantus Bioscience Holdings Inc AMBS:Over The Counter Mkt

*Data is delayed | Exchange | USD
Last | 04/15/24 EDT
0.0001UNCH (UNCH)
52 week range
0.00 - 0.00
Loading...
  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date12/15/23
  • 52 Week Low0.00
  • 52 Week Low Date04/15/24

Key Stats

  • Market Cap63,060.738
  • Shares Out630.61M
  • 10 Day Average Volume121,230.25
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-80

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close0.0001
  • 52 Week High0.00
  • 52 Week High Date12/15/23
  • 52 Week Low0.00
  • 52 Week Low Date04/15/24
  • Market Cap63,060.738
  • Shares Out630.61M
  • 10 Day Average Volume121,230.25
  • Dividend-
  • Dividend Yield-
  • Beta1.18
  • YTD % Change-80

RATIOS/PROFITABILITY

  • EPS (TTM)-3.35
  • P/E (TTM)-0.00
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-20.831M
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-58.86%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Amarantus Bioscience Holdings Inc

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Amarantus Bioscience Holdings, Inc. is a biopharmaceutical company. The Company is focused on developing therapeutic product candidates in the areas of neurology, psychiatry, ophthalmology and regenerative medicine. The Company owns or has licenses to various product candidates in the biopharmaceutical healthcare industry. It has acquired the rights to the engineered skin substitute program (ESS), a regenerative medicine-based approach for treating severe burns with...
Gerald Commissiong
President, Chief Executive Officer, Director
Barney Monte
Chief Financial Officer, Interim Chief Operating Officer
Address
655 Montgomery Street, Suite 900
San Francisco, CA
94111
United States

Top Peers

SYMBOLLASTCHG%CHG
SNNAQ
Sienna Biopharmaceuticals Inc
0.00UNCHUNCH
TLOG
TetraLogic Pharmaceuticals Corp
0.0001UNCHUNCH
CALA
Calithera Biosciences Inc
0.05UNCHUNCH
CFRXQ
ContraFect Corp
0.0233UNCHUNCH
BNTC
Benitec Biopharma Inc
4.91-0.59-10.73%